Quick Answer
Autolus Therapeutics plc reported Earnings Per Share Diluted of $1.08 (loss) per share for the year ending 2025.
- Autolus Therapeutics plc showed a decrease of -25.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Autolus Therapeutics plc's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Autolus Therapeutics plc's Earnings Per Share Diluted has grown by 62.5%.
- Historical annual values: Fiscal year 2025: $1.08 (loss) per share | Fiscal year 2024: $0.86 (loss) per share | Fiscal year 2023: $1.20 (loss) per share | Fiscal year 2022: $1.57 (loss) per share | Fiscal year 2021: $1.97 (loss) per share | Fiscal year 2020: $2.76 (loss) per share | Fiscal year 2019: $2.88 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: